Business

Regulatory Approval

Regulatory Approval.

articleEco Animal Health Group PlcApril 2, 20193/company/eco-animal-health-group-plc/news/regulatory-approval-8
Regulatory Approval

About this update from Eco Animal Health Group Plc

[{"type":"text","content":"\n \n \n Regulatory Approval\n \n \n\n \n Eco Animal Health Group Plc\n \n \n\n \n \n \n 2 April 2019\n \n \n ECO Animal Health Group plc\n \n \n (AIM: EAH)\n \n \n ECO RECEIVES EUROPEAN MARKETING AUTHORISATION FOR AIVLOSIN® FOR \n BREEDING CHICKENS\n \n \n ECO Animal Health Group plc (the “Group”) is pleased to announce that \n its subsidiary ECO Animal Health Limited (ECO) has received a marketing \n authorisation from the European Medicines Agency (EMA) for the use of \n Aivlosin® 625 mg/g Water Soluble Granules (WSG) in breeding chickens.\n \n \n This approval allows ECO to market Aivlosin® 625 mg/g WSG in Europe for \n the treatment and metaphylaxis of respiratory infections caused by Mycoplasma \n gallisepticum in breeding chickens producing eggs, for hatching \n broiler stock and for replacement layers.\n \n \n Aivlosin®, ECO’s patented antimicrobial, is used under \n veterinary prescription for the treatment of a variety of economically \n important respiratory and enteric (gut) diseases in poultry and pigs.\n \n \n Marc Loomes, CEO, commented: “The EU has five per cent of the \n world’s layer and ten per cent of the world’s broiler parent stock. This \n marketing authorisation is very significant as it provides an \n opportunity to roll out the approval beyond the EU into the \n multi-million dollar large international poultry markets. This will \n enable ECO to capitalise on the considerable global potential for \n Aivlosin® which offers a safe and highly effective medication for \n Mycoplasma infections in high value breeding birds”.\n \n \n The information contained within this announcement is deemed by the \n Group to constitute inside information as stipulated under the Market \n Abuse Regulations (EU) No. 596/2014 (\"MAR\"). Upon the \n publication of this announcement via a Regulatory Information Service \n (\"RIS\"), this inside information is now considered to be in the public \n domain.\n \n \n Contacts:\n \n \n ECO Animal Health Group plc\n \n \n \n \n Marc Loomes\n \n \n  \n \n \n 020 8447 6906\n \n \n \n \n \n Spiro Financial\n \n \n \n \n \n \n \n \n \n Anthony Spiro\n \n \n \n \n 020 8336 6196\n \n \n \n \n \n IFC Advisory Ltd\n \n \n Graham Herring, Miles Nolan\n \n \n \n \n \n 0203 934 6630\n \n \n \n \n \n N+1 Singer (Nominated Adviser and Joint Broker)\n \n \n \n \n \n \n 020 ...

More updates from Eco Animal Health Group Plc